Skip to main content

Myth: Administration of active vitamin D metabolites is beneficial in patients with advanced chronic renal failure (pre end-stage renal disease)

  • Chapter
  • 83 Accesses

Abstract

The role of calcitriol in the management of the predialysis patient is not fully defined. Of more then 20 articles on the subject, most indicate that low dosages of calcitriol, 0.25 mcg/day, or low dosages of alfacalcidiol, are safe and effective in retarding progression of renal osteodystrophy. In addition, small doses of calcitriol and alfacalcidiol are rarely associated with renal function impairment so long as calcium levels are carefully monitored.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Hamdy N. Effect of alfacalcidiol on natural course of renal bone disease in mild to moderate renal failure. Br Med J. 1995;310:358–363.

    Article  CAS  Google Scholar 

  2. Baker LR, Abrams I. l,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial. Kidney Int. 1989;35:661–669.

    Article  PubMed  CAS  Google Scholar 

  3. Goodman WG, Coburn JW. The use of 1,25-dihydroxyvitamin D in early renal failure. Annu Rev Med. 1992;43:227–237.

    Article  PubMed  CAS  Google Scholar 

  4. Tsukamoto Y, Moriya R, Nagaba Y, Morishita T, Izumida I, Okubo M. Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialysed patients with chronic renal failure. Am J Kidney Dis. 1995;25:879–887.

    Article  PubMed  CAS  Google Scholar 

  5. Slatopolsky E, Berkoben M, Kelber J, et al. Effect of calcitriol and non-calcemic vitamin D analogs on secondary hyperparathyroidism in nondialysed patients with chronic renal failure. Kidney Int. 1992;38(Supplement):S43.

    CAS  Google Scholar 

  6. Massry SG, Goldstein DA. Is calcitriol harmful to renal function? JAMA. 1979;242:1875–1876.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

von Hardenberg, H. (2002). Myth: Administration of active vitamin D metabolites is beneficial in patients with advanced chronic renal failure (pre end-stage renal disease). In: Friedman, E.A., Anees, I. (eds) Myths and Shibboleths in Nephrology. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0407-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-94-010-0407-7_16

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-0616-6

  • Online ISBN: 978-94-010-0407-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics